The zoonotic emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing coronavirus disease 2019 (COVID-19) pandemic have profoundly affected …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of
concern, first identified in November 2021, rapidly spread worldwide and diversified into …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
detected in almost all organs of coronavirus disease-19 patients, although some organs do …

Targeting angiotensin-converting enzyme 2 (ACE2) represents a promising and effective
approach to combat not only the COVID-19 pandemic but also potential future pandemics …

SARS-CoV-2 and filovirus enter cells via the cell surface angiotensin-converting enzyme 2
(ACE2) or the late-endosome Niemann-Pick C1 (NPC1) as a receptor. Here, we screened …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has substantially damaged the global economy and human health. The …

The human coronavirus HKU1 spike (S) glycoprotein engages host cell surface sialoglycans
and transmembrane protease serine 2 (TMPRSS2) to initiate infection. The molecular basis …

The recent discovery that TMEM106B serves as a receptor mediating ACE2-independent
SARS-CoV-2 entry into cells deserves attention, especially in the background of the frequent …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), like other coronaviruses,
replicates their genome in virus-induced cytosolic membrane-bound replication organelles …

Unhealthy aging poses a global challenge with profound healthcare and socioeconomic
implications. Slowing down the aging process offers a promising approach to reduce the …